Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471175 | SCV000562738 | likely benign | Juvenile polyposis syndrome | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001024712 | SCV001186780 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001024712 | SCV001351997 | likely benign | Hereditary cancer-predisposing syndrome | 2020-01-28 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000471175 | SCV005406370 | benign | Juvenile polyposis syndrome | 2024-08-01 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV000471175 | SCV005424029 | likely benign | Juvenile polyposis syndrome | 2024-03-14 | criteria provided, single submitter | clinical testing |